SUMMARY OF DISTRIBUTION AGREEMENT
TERMS


Concurrently
herewith the parties are entering into a Regulation S Subscription Agreement and Investment Representation
whereby Medpac Asia Pacific Pty Ltd “Medpac” is acquiring a Convertible Note (the “Note”) of
Event Cardio Group, Inc. (“ECGI”), in the original principal amount of $ US 500,000. As a condition to its purchase
of the Note, Medpac requested and ECGI agreed to enter into distribution agreements with respect to ECGI’s Breastcare and
Now Cardio devices.


The parties
have determined to execute this Summary of Distribution Agreement Terms at this time and to execute and deliver individual distribution
agreements with respect to each jurisdiction within the territories to be subject to the Distribution Agreements at the time ECGI
is able to deliver a product and is prepared to commence distribution in each jurisdiction.


Principal Terms of Distribution
Agreements:


There will
be two Distribution Agreements. One will grant rights with respect to ECGI’s Breastcare device for the detection of cancer
within the breast and all improvements thereto related to the detection of disease within the breast. The other will grant rights
with respect to ECGI’s Now Cardio device and all improvements thereto related to the detection of heart disease.


Breastcare
Device 


		1.	Nature of Agreement – exclusive distribution rights within the Territory. The Territory consists
of Australia, New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Laos, Cambodia, Myanmar and Bangledesh
(the “Territory”). No other distributor will be appointed within the Territory and Main Street will be compensated
in the event another distributor sells product delivered into the Territory.



 


		2.	Term – an initial term of five years with a renewal right in favor of Medpac for an additional
five years provided that a mutually agreed upon sales level is achieved. It is anticipated that the sales levels for the Territory
and the specific countries within the Territory, individually and collectively will be agreed between the parties within 120 days
of signing of this agreement for the initial term. The agreement will be terminable during the first five years if requisite annual
sales levels are not achieved and the Medpac has not purchased mutually agreed upon amounts. Provided that the sales levels are
achieved within the first five year term the Agreement will automatically renew for a further 5 years. The initial term will commence
on the first day of the month succeeding the month in which ECGI is able to deliver product to the individual countries within
the Territory.



 


		3.	Price – the price of the product will be mutually agreed between ECGI and Medpac and will
be FOB, a USA port, and will be no more than 40% of the recommended retail price for the product sold in the United States which
is anticipated to be $ US 40. Pricing will be based on the FOB USA price until such time as
a manufacturing facility is developed in Southeast Asia. If a manufacturing facility is not developed in Southeast Asia within
two years, the parties will have the option to form a joint venture to do so.



 


		4.	Customer Support – to be provided by Medpac.



 


		5.	Terms – all orders to be shipped within thirty (30) days of receipt of order and paid for
within sixty (60) days of receipt of product by Medpac.



 


		6.	Pricing by Medpac is to be determined by Medpac but to be similar to the USA RRP allowing for currency
exchange & shipping costs.



 


		7.	Cross-License – Should Medpac develop any improvements to the Breastcare device, such improvement
shall be deemed licensed to ECGI in perpetuity for no additional consideration.



 


		8.	Regulatory Approvals - Medpac is to be responsible for obtaining all regulatory approvals necessary
from each jurisdiction within the Territory provided that ECGI provides such assistance and information as may reasonably be requested.



 






    	 



    	 



    

Now Cardio 


 


		1.	Nature of Agreement – exclusive distribution rights within the Territory. No other distributor
will be appointed within the Territory and Medpac will be compensated in the event another distributor sells product delivered
into the Territory.



 


		2.	Term – an initial term of five years with a renewal right in favor of Medpac for an additional
five years provided that a mutually agreed upon sales level is achieved. It is anticipated that the sales levels for the Territory
and the specific countries within the Territory, individually and collectively will be agreed between the parties within 120 days
of signing of this agreement for the initial term. The agreement will be terminable during the first five years if requisite annual
sales levels are not achieved and Medpac has not purchased mutually agreed upon amounts. Provided that the sales levels are achieved
within the first five year term the Agreement will automatically renew for a further 5 years. The initial term will commence on
the first day of the month succeeding the month in which ECGI is able to deliver product to the individual countries within the
Territory.



 


		3.	Price - the price of the product will be mutually agreed between ECGI and Medpac and will be FOB,
a USA port, and will be no more than 40% of the recommended retail price for the product sold in the United States. Pricing will
be based on the FOB USA price until such time as a manufacturing facility is developed in Southeast Asia.



 


		4.	Customer Support – to be provided by Medpac.



 


		5.	Terms – all orders to be shipped within thirty (30) days of receipt of order and paid for
within sixty (60) days of receipt of product by Medpac.



 


		6.	Pricing by Medpac is to be determined by Medpac but to be similar to the USA RRP allowing for currency
exchange & shipping costs.



 


		7.	Cross-License – should Medpac develop any improvements to the Now Cardio device, such improvement
shall be deemed licensed to ECGI in perpetuity for no additional consideration.



 


		8.	Regulatory Approvals – Medpac is to be responsible for obtaining all regulatory approvals
necessary from each jurisdiction within the Territory provided that ECGI provides such assistance and information as may reasonably
be requested.



 


 


	 	Medpac Asia Pacific Pty. Ltd.	 	Event
Cardio Group, Inc.
	 	 	 	 
	 	By:	 	By:
	 	Ian Kellaway	 	John Bentivoglio
	 	Director	 	 President